@karolinskainst just deactivated X - follow on Bluesky instead! (Tempted to reproduce the full switch…)

RT @TheLancetEndo: The Lancet Diabetes & Endocrinology has joined Bluesky! 🦋Find and follow us at 🌐And, of cour…

Only about 20% of patients were estimated to be alive without lung disease or liver cirrhosis 20 years after an AATD diagnosis, showing the need for novel treatments. Thanks to all involved! @staffan_wahlin @karolinskainst

We are looking for a talented statistician with a focus on teaching and education to our group for a full-time position. Your role will be to help junior researchers at @karolinskainst thrive and produce the best possible research Please retweet!

RT @sparrelid: It’s time to find the 4th person for our international clinical and research HPB fellowship @HpbKarolinska starting Septembe…

Huge thanks to all involved researchers, especially 1st author dr Andrea Lindfors and statistician Rickard Strandberg, the nurses performing the initial screening, the funders, Capio Ögon for the collaboration, @LancetGastroHep for publishing, and all patients for participating.

Should we better look out for pancreatic disease in our ALD patients? Thanks to first author @AnaDugic and great input from @maloehr1 . As always excellent statistical work by our principal statistician Linnea Widman. @karolinskainst #livertwitter

RT @EASLnews: 🚨Reminder: Last chance to submit your abstract to #EASLCongress 2025! 🚨 Deadline: TOMORROW, 3 December 2024 🌷Share your wor…

RT @CLDFoundation: Registration is open for the ALD-ALLY Conference taking place on Friday, April 4, 2025. Be an ALLY and join us in New Yo…

RT @tomhemmingk: We put some provocative statements herein, hope to see a good discussion:

Will start to post more on @bluesky and likely less here. Follow at 🤟🏻 Quite many from the liver community moving over. ☺️

In @JInternMed this week: Statin-associated regulation of hepatic PNPLA3 in patients without known liver disease.